Health

Results: 1009-1020 of 9182

PR Newswire associated0

Emboline Announces Positive Pivotal PROTECT H2H Trial Results for Emboliner® Presented as a Late-Breaking Clinical Trial at ACC 2026

HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)

PR Newswire associated0

CGBIO Showcases Minimally Invasive Spine Surgery Techniques in Thailand: "Smaller Incisions, Faster Recovery"

Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform

PR Newswire associated0

IFPA launches first Africa Forum on psoriasis calling for urgent action on overlooked disease

Presswire associated0

LONG-TERM HEAVY CANNABIS USE LINKED TO THINNING IN FRONTAL BRAIN REGION

Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy

PR Newswire associated0

Lunit, CellCarta Announce Strategic Collaboration to Accelerate AI-Enabled Digital Pathology for Companion Diagnostic Programs

EMA validates indication extension application for Tryngolza® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG)

PR Newswire associated0

4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union